| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 125, 2710-2718, Copyright © 1989 by Endocrine Society
ARTICLES |
L Stefaneanu, K Kovacs, E Horvath, SL Asa, NE Losinski, N Billestrup, J Price and W Vale
Department of Pathology, St. Michael's Hospital, University of Toronto, Ontario, Canada.
The effect of protracted GH-releasing factor (GRF) stimulation on adenohypophysial morphology was investigated in six mice transgenic for human GRF (hGRF). All animals had significantly higher plasma levels of GH and GRF and greater body weights than controls. Eight-month-old mice were killed, and the markedly enlarged pituitaries were studied by histology, immunocytochemistry, electron microscopy, and immunogold method, using double labeling at ultrastructural level. In all pituitaries, a massive hyperplasia, chiefly of mammosomatotrophs, was found. These bihormonal cells, containing GH and PRL, were demonstrated by light microscopy and ultrastructural immunocytochemistry. Electron microscopy revealed the presence of cells with characteristics of GH cells in three pituitaries and cells resembling human adenomatous mammosomatotrophs in the other three glands. All of these cells, regardless of their ultrastructural features, contained secretory granules heavily labeled for GH by immunogold technique; PRL labeling varied from cell to cell, with the predominance of a weak immunostaining and was colocalized with GH in secretory granules. These results indicate that chronic exposure to GRF excess leads to mammosomatotroph hyperplasia. It is suggested that GH cells proliferate and transform to mammosomatotrophs in response to GRF stimulation. Focal PRL cell hyperplasia noted in three pituitaries could also be due to a GRF effect. Longer exposure to GRF is needed to clarify whether GRF can cause adenoma.
This article has been cited by other articles:
![]() |
M. J E Walenkamp, S. Vidarsdottir, A. M Pereira, M. Karperien, J. van Doorn, H. A van Duyvenvoorde, M. H Breuning, F. Roelfsema, M F. Kruithof, J. van Dissel, et al. Growth hormone secretion and immunological function of a male patient with a homozygous STAT5b mutation Eur. J. Endocrinol., February 1, 2007; 156(2): 155 - 165. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Pals, M. Boussemaere, E. Swinnen, H. Vankelecom, and C. Denef A Pituitary Cell Type Coexpressing Messenger Ribonucleic Acid of Proopiomelanocortin and the Glycoprotein Hormone {alpha}-Subunit in Neonatal Rat and Chicken: Rapid Decline with Age and Reappearance in Vitro under Regulatory Pressure of Corticotropin-Releasing Hormone in the Rat Endocrinology, October 1, 2006; 147(10): 4738 - 4752. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. V. Dimaraki, W. F. Chandler, M. B. Brown, C. A. Jaffe, S. Y. Kim, R. Taussig, V. Padmanabhan, and A. L. Barkan The Role of Endogenous Growth Hormone-Releasing Hormone in Acromegaly J. Clin. Endocrinol. Metab., June 1, 2006; 91(6): 2185 - 2190. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. T. McElvaine and K. E. Mayo A Dominant-Negative Human Growth Hormone-Releasing Hormone (GHRH) Receptor Splice Variant Inhibits GHRH Binding Endocrinology, April 1, 2006; 147(4): 1884 - 1894. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Huerta-Ocampo, H. C. Christian, N. M. Thompson, M. M. El-Kasti, and T. Wells The Intermediate Lactotroph: A Morphologically Distinct, Ghrelin-Responsive Pituitary Cell in the Dwarf (dw/dw) Rat Endocrinology, November 1, 2005; 146(11): 5012 - 5023. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. Mayo, L. J. Miller, D. Bataille, S. Dalle, B. Goke, B. Thorens, and D. J. Drucker International Union of Pharmacology. XXXV. The Glucagon Receptor Family Pharmacol. Rev., March 1, 2003; 55(1): 167 - 194. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Asa, K. T. Coschigano, L. Bellush, J. J. Kopchick, and S. Ezzat Evidence for Growth Hormone (GH) Autoregulation in Pituitary Somatotrophs in GH Antagonist-Transgenic Mice and GH Receptor-Deficient Mice Am. J. Pathol., March 1, 2000; 156(3): 1009 - 1015. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Moore Jr., A. Cai, M. E. Hostettler, L. A. Arbogast, J. L. Voogt, and J. F. Hyde Pituitary Hormone Gene Expression and Secretion in Human Growth Hormone-Releasing Hormone Transgenic Mice: Focus on Lactotroph Function Endocrinology, January 1, 2000; 141(1): 81 - 90. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Stefaneanu, L. Powell-Braxton, W. Won, V. Chandrashekar, and A. Bartke Somatotroph and Lactotroph Changes in the Adenohypophyses of Mice with Disrupted Insulin-Like Growth Factor I Gene Endocrinology, September 1, 1999; 140(9): 3881 - 3889. [Abstract] [Full Text] |
||||
![]() |
J. P. Moore Jr., A. Cai, B. E. Maley, L. Jennes, and J. F. Hyde Galanin within the Normal and Hyperplastic Anterior Pituitary Gland: Localization, Secretion, and Functional Analysis in Normal and Human Growth Hormone-Releasing Hormone Transgenic Mice Endocrinology, April 1, 1999; 140(4): 1789 - 1799. [Abstract] [Full Text] |
||||
![]() |
E. E. Muller, V. Locatelli, and D. Cocchi Neuroendocrine Control of Growth Hormone Secretion Physiol Rev, April 1, 1999; 79(2): 511 - 607. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |